The statistic depicts the projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 . In 2020, the Japanese biopharmaceutical market was forecasted to reach approximately 500 billion Japanese yen, up from around 245 billion yen in 2011.
Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2022-2028
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Patented drug products annual sales in Canada 1990-2021
- Premium Statistic Veterinary vaccines market share worldwide in 2016, by technology
- Premium Statistic Global biotechnology market share by region 2012
- Basic Statistic Top drugs based on projected 2023 global sales
- Premium Statistic Top global biotech companies - R&D expenditure 2022
- Premium Statistic Biosimilar market size Japan 2018-2030
- Basic Statistic Major biotech IPOs 2021
- Basic Statistic Percentage of biotech therapies in development as of 2017, by developer
About the region
10
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Fuji Pharma's R&D costs FY 2013-2022
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Premium Statistic Daiichi Sankyo's total employees FY 2012-2021
- Premium Statistic Sawai Pharmaceutical's employee numbers 2012-2021
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's net income FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's revenue in FY 2016, by segment
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
Selected statistics
5
- Premium Statistic R&D expenditure in U.S. biotechnology 2009-2010 by type
- Basic Statistic MorphoSys' research & development expenditure 2006-2022
- Basic Statistic Celgene's revenue and net income 2006-2018
- Premium Statistic Key figures on established biotech centers worldwide 2012-2016
- Premium Statistic MorphoSys' revenue 2006-2022
Other regions
10
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Premium Statistic Research and development in European pharmaceutical industry by country 2021
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Drug products patented sales share in Canada, by therapeutic class 2021
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Number of employees at Sobi 2013-2022
- Premium Statistic R&D employees of the pharmaceutical company Chiesi 2020, by country
- Premium Statistic Sold packaging units of phytopharmaceuticals in Germany in 2020, by sales channel
Related statistics
10
- Premium Statistic Production value of medical devices Japan 2012-2021
- Premium Statistic R&D spending of pharmaceutical companies Japan FY 2015-2021
- Premium Statistic Daiichi Sankyo's net income FY 2012-2021
- Premium Statistic Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Basic Statistic Takeda Pharmaceutical's revenue FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's number of employees FY 2013-2022
- Premium Statistic Otsuka Holdings' total assets FY 2013-2022
- Premium Statistic Otsuka Holdings' operating income FY 2013-2022
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2023
- Premium Statistic Taisho Pharmaceutical's employee number FY 2013-2020
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- Sanofi's total assets 2007-2022
- AstraZeneca's expenditure on research and development 2006-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- Sanofi's total assets 2007-2022
- AstraZeneca's expenditure on research and development 2006-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
JETRO. (December 1, 2017). Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen) [Graph]. In Statista. Retrieved December 08, 2023, from https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/
JETRO. "Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen)." Chart. December 1, 2017. Statista. Accessed December 08, 2023. https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/
JETRO. (2017). Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen). Statista. Statista Inc.. Accessed: December 08, 2023. https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/
JETRO. "Projected Market Size of The Biopharmaceutical Industry in Japan from 2011 to 2020 (in Billion Japanese Yen)." Statista, Statista Inc., 1 Dec 2017, https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/
JETRO, Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen) Statista, https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/ (last visited December 08, 2023)
Projected market size of the biopharmaceutical industry in Japan from 2011 to 2020 (in billion Japanese yen) [Graph], JETRO, December 1, 2017. [Online]. Available: https://www.statista.com/statistics/827752/japan-biopharmaceutical-market-size-forecast/